MPM ASSET MANAGEMENT LLC - Q4 2020 holdings

$707 Million is the total value of MPM ASSET MANAGEMENT LLC's 8 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 25.0% .

 Value Shares↓ Weighting
ITOS  iTeos Therapeutics, Inc.$125,359,000
+37.1%
3,706,6630.0%17.74%
+4.0%
TCRR  TCR2 Therapeutics, Inc.$125,293,000
+52.2%
4,050,8650.0%17.73%
+15.5%
DYN  Dyne Therapeutics, Inc.$103,977,000
+4.0%
4,951,3030.0%14.71%
-21.1%
RPTX  Repare Therapeutics, Inc.$103,029,000
+11.5%
3,003,7720.0%14.58%
-15.4%
ONCR NewOncorus, Inc.$92,123,0002,849,464
+100.0%
13.04%
HARP  Harpoon Therapeutics, Inc.$75,151,000
-2.2%
4,524,4250.0%10.64%
-25.8%
RYTM  Rhythm Pharmaceuticals, Inc.$56,762,000
+37.2%
1,909,2580.0%8.03%
+4.1%
CHMA  Chiasma, Inc.$24,953,000
+1.2%
5,736,2960.0%3.53%
-23.2%
SNDX ExitSyndax Pharmaceuticals, Inc.$0-1,843,388
-100.0%
-5.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Proteon Therapeutics, Inc.17Q4 20183.0%
EpiZyme, Inc.15Q4 201635.9%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (706648000.0 != 706647000.0)

Export MPM ASSET MANAGEMENT LLC's holdings